ranolazine 375 mg prolonged-release tablet
elc group s.r.o. - ranolazine - prolonged-release tablet - ranolazine
ranolazine 500 mg prolonged-release tablet
elc group s.r.o. - ranolazine - prolonged-release tablet - ranolazine
ranolazine 750 mg prolonged-release tablet
elc group s.r.o. - ranolazine - prolonged-release tablet - ranolazine
pedea
recordati rare diseases - ibuprofen - ductus arteriosus, patent - cardiac therapy - treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age.
co q 10 - 50mg cap capsule
albi naturals - ubidecarenone - capsule - 50mg - ubidecarenone 50mg - other nutritional agents
rocky mountain co q 10 cap 25mg capsule
albi naturals - ubidecarenone - capsule - 25mg - ubidecarenone 25mg - other nutritional agents
coenzyme q-10 60 mg capsule
vita health products inc - ubidecarenone - capsule - 60mg - ubidecarenone 60mg - other nutritional agents
coenzyme q-10 - 30 mg capsule
vita health products inc - ubidecarenone - capsule - 30mg - ubidecarenone 30mg - other nutritional agents
co-enzyme q-10 capsule
seroyal international inc. - ubidecarenone - capsule - 30mg - ubidecarenone 30mg - other nutritional agents
co-enzyme q-10 capsule
holista health (canada) inc. - ubidecarenone - capsule - 30mg - ubidecarenone 30mg - other nutritional agents